What kind of medicine is Anamorelin?

Anamorelin (Anamorelin) is an innovative drug mainly used to treat cancer cachexia (Cancer Cachexia), a complex metabolic syndrome common in patients with advanced cancer.

Anamulin is a selective peptide receptor agonist (Selective Peptide Receptor Agonist, SPRA), which simulates the physiological effects of ghrelin by binding to the receptor of growth hormone releasing peptide (ghrelin). ghrelin is an important appetite-regulating hormone that can stimulate appetite, promote food intake and increase weight. Anamorelin helps improve appetite and nutritional status in patients with cancer cachexia by activating this receptor.

Anamorelin is mainly used to treat cancer cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer and other malignant tumors. These patients are often accompanied by symptoms such as severe weight loss, muscle wasting, and loss of appetite, which seriously affect the quality of life and treatment effects. Multiple randomized controlled clinical trials have shown that anamorelin can significantly increase patients' body weight and lean body mass (ie, muscle mass), while improving patients' appetite and quality of life.

The safety of anamorelin has been verified in clinical trials, but patients still need to pay attention to some things when using it. First of all, anamorelin may cause some side effects, such as abnormalities of the cardiac conduction system, hyperglycemia, liver dysfunction, etc. Therefore, patients need to undergo a comprehensive physical examination and consult a professional physician before using anamorelin. Secondly, anamorelin is usually used as an auxiliary treatment, and comprehensive treatment strategies including nutritional support, anti-tumor treatment, psychological support, etc. are very important.